Theriva Biologics, Inc. (TOVX)

Theriva Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.01	11.61	23.18	41.79	67.33	6.23
Cash & Short-Term Investments	10.01	11.61	23.18	41.79	67.33	6.23
Cash Growth	-45.16%	-49.91%	-44.53%	-37.93%	981.18%	-58.61%
Other Receivables	1.7	3.32	1.94	0.23	-	0.47
Receivables	1.7	3.32	1.94	0.23	-	0.47
Prepaid Expenses	0.69	0.98	1.17	1.21	1.08	0.77
Other Current Assets	0.08	0.37	1.12	2.29	0.46	0.47
Total Current Assets	12.48	16.28	27.4	45.52	68.86	7.93
Property, Plant & Equipment	1.42	1.54	2.18	1.54	1.48	0.45
Goodwill	-	-	5.7	5.53	-	-
Long-Term Deferred Charges	18.08	17.36	19.76	19.15	-	-
Other Long-Term Assets	0.18	0.17	0.18	0.12	0.02	0.02
Total Assets	32.16	35.35	55.22	71.86	70.37	8.41
Accounts Payable	0.44	0.86	0.77	0.92	0.52	0.89
Accrued Expenses	4.32	4.51	4.51	2.9	2.91	1.79
Current Portion of Long-Term Debt	0.05	0.06	0.06	0.06	-	-
Current Portion of Leases	0.57	0.54	0.49	0.22	0.12	0.29
Other Current Liabilities	2.77	1.61	0.91	2.97	-	-
Total Current Liabilities	8.15	7.59	6.74	7.06	3.55	2.97
Long-Term Debt	1.5	0.09	0.16	0.22	-	-
Long-Term Leases	0.73	0.87	1.44	1.19	1.4	0.19
Long-Term Deferred Tax Liabilities	-	-	-	1.62	-	-
Other Long-Term Liabilities	6.28	7.74	7.18	7.21	-	-
Total Liabilities	16.66	16.29	15.52	17.3	4.96	3.15
Common Stock	0	0	0	0.02	0.01	0.03
Additional Paid-In Capital	355.6	355.5	346.54	343.75	336.68	240.82
Retained Earnings	-339.3	-334.97	-309.32	-290.97	-271.28	-248.09
Treasury Stock	-0.29	-0.29	-0.29	-0.29	-	-
Comprehensive Income & Other	-0.52	-1.18	0.03	-0.68	-	-
Total Common Equity	15.5	19.07	36.96	51.83	65.41	-7.24
Minority Interest	-	-	-	-	-	-2.77
Shareholders' Equity	15.5	19.07	39.7	54.56	65.41	5.26
Total Liabilities & Equity	32.16	35.35	55.22	71.86	70.37	8.41
Total Debt	2.86	1.57	2.15	1.68	1.53	0.47
Net Cash (Debt)	7.16	10.04	21.02	40.11	65.8	5.75
Net Cash Growth	-55.93%	-52.22%	-47.58%	-39.05%	1043.52%	-59.83%
Net Cash Per Share	3.82	7.45	32.63	65.41	134.97	75.67
Filing Date Shares Outstanding	8.19	2.78	0.69	0.6	0.63	0.52
Total Common Shares Outstanding	2.78	2.78	0.69	0.6	0.53	0.12
Working Capital	4.33	8.7	20.67	38.46	65.3	4.97
Book Value Per Share	5.57	6.85	53.89	85.67	123.84	-61.91
Tangible Book Value	15.5	19.07	31.26	46.31	65.41	-7.24
Tangible Book Value Per Share	5.57	6.85	45.58	76.54	123.84	-61.91
Machinery	0.71	0.71	0.9	0.9	0.83	0.81
Leasehold Improvements	0.09	0.09	0.09	0.09	0.09	0.44

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q